patent/MY-137969-A

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b6042509de7544921c96de43b9da1438
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-407 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-04
filingDate	2006-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b60ae85406155bf474c75e6372655400
publicationDate	2009-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	MY-137969-A
titleOfInvention	Crystal form of asenapine maleate
abstract	THE INVENTION RELATES TO AN ORTHORHOMBIC CRYSTAL FORM OF COMPOUND TRANS-5-CHLORO-2,3,3A, 12B-TETRAHYDRO-2-METHYL-1 H-DIBENZ [2,3:6,7] OXEPINO [4,5-C] PYRROLE (Z)-2- BUTENEDIOATE, TO METHODS FOR THE PREPARATION OF THIS CRYSTAL FORM AND TO PHARMACEUTICAL COMPOSITIONS COMPRISING AN ORTHORHOMBIC CRYSTAL FORM.
priorityDate	2005-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6917875 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449104644

Total number of triples: 15.